Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co. KGaA    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

FRESENIUS SE : Warburg Research remains its Buy rating

10/29/2020 | 07:06am EST

In a research note, Warburg Research analyst Ulrich Huwald has maintained his recommendation on the stock with a Buy rating. The target price remains set at EUR 63.


© MarketScreener with dpa-AFX Analyser 2020
Stocks mentioned in the article
ChangeLast1st jan.
FRESENIUS MEDICAL CARE AG & CO. KGAA 0.10% 57.76 Delayed Quote.-15.31%
FRESENIUS SE & CO. KGAA 1.32% 35.97 Delayed Quote.-4.94%
All news about FRESENIUS SE & CO. KGAA
03/01DGAP-DD  : Fresenius Medical Care AG & Co. KGaA english
DJ
03/01FMC FRESENIUS MEDICAL CARE AG & CO K : Buy rating from Berenberg
MD
02/26PRESS RELEASE  : Nanogate SE: Divestment of Nanogate Kierspe GmbH
DJ
02/26FMC FRESENIUS MEDICAL CARE AG & CO K : Buy rating from Goldman Sachs
MD
02/26FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Neutral rating from JP Morgan
MD
02/26FRESENIUS SE  : JP Morgan gives a Buy rating
MD
02/25FRESENIUS SE & CO. KGAA : Release according to Article 40, Section 1 of the WpHG..
EQ
02/25FMC FRESENIUS MEDICAL CARE AG & CO K : Independant Research reiterates its Buy r..
MD
02/25DGAP-DD  : Fresenius SE & Co. KGaA english
DJ
02/25DGAP-DD  : Fresenius Medical Care AG & Co. KGaA english
DJ
More news
Financials
Sales 2020 36 158 M 43 229 M 43 229 M
Net income 2020 1 735 M 2 075 M 2 075 M
Net Debt 2020 23 519 M 28 119 M 28 119 M
P/E ratio 2020 11,4x
Yield 2020 2,24%
Capitalization 20 055 M 24 154 M 23 977 M
EV / Sales 2020 1,21x
EV / Sales 2021 1,13x
Nbr of Employees 309 114
Free-Float 72,0%
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 45,55 €
Last Close Price 35,97 €
Spread / Highest target 89,0%
Spread / Average Target 26,6%
Spread / Lowest Target -50,9%
EPS Revisions
Managers and Directors
NameTitle
Stephan Sturm President & Chief Executive Officer
Rachel Clare Empey Chief Financial Officer
Gerd Krick Chairman-Supervisory Board
Jürgen Götz Chief Legal & Compliance Officer
Niko Stumpfögger Deputy Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
FRESENIUS SE & CO. KGAA-4.94%24 154
AIER EYE HOSPITAL GROUP CO., LTD.-14.82%43 862
TOPCHOICE MEDICAL CORPORATION-16.13%12 775
RAMSAY HEALTH CARE LIMITED4.37%11 963
IHH HEALTHCARE-0.55%11 915
BANGKOK DUSIT MEDICAL SERVICES3.85%10 954